TITLE

Lymphedema fear is greater than risk

PUB. DATE
March 2013
SOURCE
Oncology Nurse Advisor;Mar/Apr2013, Vol. 4 Issue 2, p8
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses a study conducted by Sarah McLaughlin, assistant surgery professor at the Mayo Clinic in Florida, and her colleagues about lymphedema rate (LR), patient worry and risk-reduction behaviors in women undergoing breast cancer surgery. The researchers evaluated 67 patients who underwent sentinel lymph node (SLNB) biopsy and 53 women treated with axillary LN dissection (ALND). They found that LR is higher among ALND patients than SLNB patients.
ACCESSION #
88088608

 

Related Articles

  • A Cross-sectional Study Examining the Risk Factors Associated with Lymphedema and its Prevalence in Breast Cancer Patients after Level 3 Axillary Lymph Node Dissection. KİBAR, Sibel; ARAS, Meltem DALYAN; DELİALİOĞLU, Sibel ÜNSAL; KÖSEOĞLU, Belma Füsun // Turkish Journal of Physical Medicine & Rehabilitation / Turkiye ;Mar2015, Vol. 61 Issue 1, p36 

    Objective: To determine the prevalance of lymphedema after breast cancer treatment with level 3 axillary lymph node dissection (ALND) and to evaluate the risk factors which underlie this condition. Material and Methods: A total of 190 women >18-years-old who underwent breast cancer treatment...

  • On-site lab reduces repeat surgeries.  // Oncology Nurse Advisor;Mar/Apr2012, Vol. 3 Issue 2, p11 

    No abstract available.

  • The Ever-Changing Role of Sentinel Lymph Node Biopsy in the Management of Breast Cancer. Goodman, Steven; O¿Connor, Ashling; Kandil, Dina; Khan, Ashraf // Archives of Pathology & Laboratory Medicine;Jan2014, Vol. 138 Issue 1, p57 

    Context.-Axillary nodal status remains one of the most important prognostic indicators in the management of breast cancer. Axillary node metastases are seen in fewer than half of breast cancer cases, and axillary lymph node dissection is associated with significant morbidity. Sentinel lymph node...

  • Addressing Overtreatment in DCIS: What Should Physicians Do Now? Morrow, Monica; Katz, Steven J. // JNCI: Journal of the National Cancer Institute;Dec2015, Vol. 107 Issue 12, p1 

    The authors present insights on the ongoing debate concerning ductal carcinoma in situ (DCIS) in relation to breast cancer overtreatment. Topics discussed include the marked increase in rates of diagnosis and the failure to reduce the incidence of invasive breast cancer, the trends in treatment...

  • Early Contralateral Shoulder-Arm Morbidity in Breast Cancer Patients Enrolled in a Randomized Trial of Post-Surgery Radiation Therapy. Adriaenssens, Nele; Vinh-hung, Vincent; Miedema, Geertje; Versmessen, Harijati; Lamote, Jan; Vanhoeij, Marian; Lievens, Pierre; van Parijs, Hilde; Storme, Guy; Voordeckers, Mia; De Ridder, Mark // Breast Cancer: Basic & Clinical Research;2012, Issue 6, p79 

    Introduction: Shoulder/arm morbidity is a common complication of breast cancer surgery and radiotherapy (RT), but little is known about acute contralateral morbidity. Methods: Patients were 118 women enrolled in a RT trial. Arm volume and shoulder mobility were assessed before and 1-3 months...

  • Diagnosis and Treatment of Lymphedema in Patients With Breast Cancer. McCaulley, Lauren; Smith, Jennifer // Clinical Journal of Oncology Nursing;Oct2014, Vol. 18 Issue 5, pE97 

    Lymphedema is a distressing consequence of breast cancer treatment affecting the patient in all domains of quality of life. Early identification and diagnosis are key to preventing long-term consequences. The goal of lymphedema management is to slow the progression and provide symptomatic relief...

  • Sentinel Node Biopsy After Neoadjuvant Chemotherapy: Prechemotherapy Nodal Status Is Crucial for Test Performance. DE ANDRADE, VICTOR PIANA; LORDELLO DE MELO, LEONARDO; DE TOLEDO OSÓRIO, CYNTHIA APARECIDA BUENO; PEREIRA ANDRADE, WESLEY; ELLIOTT, ROBIN M.; SHENK, ROBERT R.; THOMPSON, CHERYL L.; GILMORE, HANNAH L. // Archives of Pathology & Laboratory Medicine;Jul2015, Vol. 139 Issue 7, p845 

    A letter to the editor and a reply are presented in response to the article "Touch preparations for the intraoperative evaluation of sentinel lymph nodes after neoadjuvant therapy have high false negative rates in patients with breast cancer," by R. M. Elliott and colleagues in the 2014 issue.

  • Sentinel Lymph Node Biopsy in Breast Cancer-Should It Be the Standard of Care in India? Chintamani // Indian Journal of Surgery;Jun2012, Vol. 74 Issue 3, p205 

    The author highlights the issue of delayed presentation of breast cancers while highlighting a study showing that delays in breast cancer diagnosis were more often due to providers than patients. He discusses the advent of Sentinel Lymph Node Biopsy (SLNB) to assess axilla without resorting...

  • Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer. Kim, Hyojin; Lee, Kyung-Hun; Park, In; Chung, Yul; Im, Seock-Ah; Noh, Dong-Young; Han, Wonshik; Moon, Hyeong-Gon; Jung, Yoon; Ryu, Han; Park, In Ae; Chung, Yul Ri; Jung, Yoon Yang; Ryu, Han Suk // Virchows Archiv;Nov2015, Vol. 467 Issue 5, p563 

    Luminal A breast cancer can present with early, unexpected lymph node metastasis, and sentinel lymph node biopsy has been reported false negative in some cases. We aimed to construct a biomarker-based model that predicts lymph node metastasis in luminal A breast cancer, using expression of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics